WATSON 415 (Estropipate 1.5 mg)

Pill imprint WATSON 415 has been identified as Estropipate 1.5 mg.

Estropipate is used in the treatment of atrophic vaginitis; atrophic urethritis; oophorectomy; primary ovarian failure; postmenopausal symptoms (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for WATSON 415

Estropipate 1.5 mg WATSON 415
Estropipate 1.5 mg WATSON 415
Estropipate 1.5 mg WATSON 415  Front
Estropipate 1.5 mg WATSON 415  Back
Estropipate
Imprint:
WATSON 415
Strength:
1.5 mg
Color:
Orange
Shape:
Round
Availability:
Prescription only
Drug Class:
Estrogens
Pregnancy Category:
X - Not for use in pregnancy
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Watson Pharmaceuticals

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)